Stay updated on Modakafusp Alfa + Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Modakafusp Alfa + Daratumumab in MM Clinical Trial page.

Latest updates to the Modakafusp Alfa + Daratumumab in MM Clinical Trial page
- Check6 days agoChange DetectedUI updates include a glossary toggle and color-coded change indicators (green for additions, red for deletions) with the new Revision: v3.4.0, replacing the previous v3.3.4.SummaryDifference0.8%

- Check13 days agoChange DetectedA new revision label v3.3.4 was added and the previous revision v3.3.3 was removed. This change only affects versioning in the history and does not impact study data or trial details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedNew history entries on 2025-12-03 and 2025-12-19 add More Information, Contacts/Locations, and Study Status, with Revision: v3.3.3. The HHS Vulnerability Disclosure entry was removed on 2025-08-06 (Revision: v3.3.2).SummaryDifference0.7%

- Check63 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and removal of v3.3.1, a routine maintenance log rather than substantive content change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision entry, v3.3.1, has been added to the page history.SummaryDifference0.1%

- Check78 days agoChange DetectedThe government funding/operating status notice banner on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Modakafusp Alfa + Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modakafusp Alfa + Daratumumab in MM Clinical Trial page.